Cingulate Inc. (CING)
NASDAQ·Healthcare·Biotechnology
$4.84
-8.08%
Mkt Cap $29.49M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | — | — | — | -$0.56 | -$0.84 | -50.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.80 | -$1.35 | -68.75% | — | — |
| Q3 2025 Aug 19, 2025 | — | — | — | -$0.82 | -$1.09 | -32.93% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$1.00 | -$1.04 | -4.00% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$1.48 | -$0.14 | +90.54% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$2.22 | -$1.83 | +17.57% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$5.64 | -$5.47 | +3.01% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$26.41 | -$7.20 | +72.74% | — | — |
| Q1 2024 Mar 29, 2024 | — | -$3.85B | — | -$4.86 | -$7.66 | -57.61% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$57.62 | -$72.03 | -25.01% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.35 | -$136.85 | -39000.00% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$64.83 | -$84.03 | -29.62% | — | — |
| Q1 2023 Mar 10, 2023 | — | — | — | -$86.43 | -$98.44 | -13.90% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.37 | -$86.43 | -23259.46% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.58 | -$86.43 | -14801.72% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.23 | -$105.64 | -45830.43% | — | — |
| Q1 2022 Mar 10, 2022 | — | — | — | -$0.39 | -$0.32 | +17.95% | — | — |
| Q4 2021 Dec 9, 2021 | — | — | — | — | -$30.40 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$324.48 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$28.31 | — | — | — |